Target intelligence / Profile preview

ZNF350 antisense RNA 1 (ZNF350-AS1)

Target
ZNF350-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-coding RNA
01

Overview

ZNF350 antisense RNA 1 (ZNF350-AS1) is a long non-coding RNA (lncRNA) gene located at chromosome 19q13.41 that does not encode a protein but instead regulates gene expression and chromatin state, often by acting as an antisense regulator for the nearby ZNF350 gene[1][4][5]. ZNF350-AS1 is reported under several aliases, notably HCCAT3, and has been implicated in the progression of multiple cancers, including hepatocellular carcinoma where its upregulation may facilitate tumor growth[3][4]. Its mechanisms include recruiting transcription factors, influencing enhancer activity, regulating alternative splicing, and potentially participating in RNA editing events[1][4]. While evidence suggests a role as a biomarker for some cancer types, there are currently no known drug interactions or targeted therapeutic agents, nor is it categorized as a therapeutic target such as a receptor or enzyme[2][3][4].

Other names
HCCAT3uc002pycCTC-429C10.4hepatocellular carcinoma associated transcript 3 (non-protein coding)
02

Biological functions

Regulation of gene expressionRegulation of alternative splicingRegulation of chromatin stateNegative regulation of target mRNAPossible enhancer activity
03

Disease associations

CancerEspecially hepatocellular carcinomaOther cancer-related roles (dysregulated in bladder cancer, breast cancer, prostate cancer, etc.)
04

Biomarkers

Possible biomarker for cancer (e.g., hepatocellular carcinoma)Differentially expressed in multiple cancer types[1][3]

Beyond the preview

Go deeper on ZNF350 antisense RNA 1 (ZNF350-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF350 antisense RNA 1 (ZNF350-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call